Residual-QSAR. Implications for genotoxic carcinogenesis

Chemistry Central Journal

Volumn 5, Issue 1, 2011, Pages

  Putz, Mihai V ^a  

^a WEST UNIVERSITY OF TIMISOARA   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79958273248     PISSN: None     EISSN: 1752153X     Source Type: Journal    
DOI: 10.1186/1752-153X-5-29     Document Type: Article

References (45)

1. Croce CM. Oncogenes and cancer. N Engl J Med 2008, 358:502-511. 10.1056/NEJMra072367, 18234754.
2. Dingli D, Nowak MA. Cancer biology: infectious tumour cells. Nature (London) 2006, 443:35-36.
3. Danaei G, Vander Hoorn S, Lopez AD, Murray CJ, Ezzati M. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 2005, 366:1784-1793. 10.1016/S0140-6736(05)67725-2, 16298215.
4. Merlo LM, Pepper JW, Reid BJ, Maley CC. Cancer as an evolutionary and ecological process. Nat Rev Cancer 2006, 6:924-935. 10.1038/nrc2013, 17109012.
5. Ward EM, Thun MJ, Hannan LM, Jemal A. Interpreting cancer trends. Ann NY Acad Sci 2006, 1076:29-53. 10.1196/annals.1371.048, 17119192.
6. Pagano JS, Blaser M, Buendia MA, Damania B, Khalili K, Raab-Traub N, Roizman B. Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol 2004, 14:453-471. 10.1016/j.semcancer.2004.06.009, 15489139.
7. Roukos DH. Genome-wide association studies: how predictable is a person's cancer risk?. Expert Rev Anticancer Ther 2009, 9:389-392. 10.1586/era.09.12, 19374592.
8. Knudson AG. Two genetic hits (more or less) to cancer. Nat Rev Cancer 2001, 1:157-162. 10.1038/35101031, 11905807.
9. Miller JA, Miller E. Ultimate chemical carcinogens as reactive mutagenic electrophiles. Origins of Human Cancer 1977, 605-628. Cold Spring Harbor: Cold Spring Harbor Laboratory, Hiatt HH, Watson JD, Winsten JA.
10. Miller EC, Miller JA. Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules. Cancer 1981, 47:2327-2345. 10.1002/1097-0142(19810515)47:10<2327::AID-CNCR2820471003>3.0.CO;2-Z, 7272889.
11. Arcos JC, Argus MF. Multifactor interaction network of carcinogenesis--a "tour guide". Chemical Induction of Cancer. Modulation and Combination Effects 1995, 1-20. Boston: Birkhauser, Arcos JC, Argus MF, Woo YT.
12. Woo YT. Mechanisms of action of chemical carcinogens, and their role in Structure-Activity Relationships (SAR) analysis and risk assessment. Quantitative Structure-Activity Relationship (QSAR) Models of Mutagens and Carcinogens 2003, 41-80. Boca Raton: CRC Press, Benigni R.
13. Benigni R, Netzeva TI, Benfenati E, Bossa C, Franke R, Helma C, Hulzebos E, Marchant C, Richard A, Woo YT, Yang C. The expanding role of predictive toxicology: an update on the (Q)SAR models for mutagens and carcinogens. J Environ Sci Health C 2007, 25:53-97.
14. Worth AP, Bassan A, de Brujin J, Gallegos Saliner A, Netzeva T, Patlewicz G, Pavan M, Tsakovska I, Eisenreich S. The role of the European chemicals bureau in promoting the regulatory use of (Q)SAR methods. SAR QSAR Environ Res 2007, 18:111-125. 10.1080/10629360601054255, 17365963.
15. Woo YT, Lai DY. OncoLogic: a mechanism-based expert system for predicting the carcinogenic potential of chemicals. Predictive Toxicology 2005, 385-413. Boca Raton: CRC Press, Helma C.
16. Lewis DFV, Bird MG, Jacobs MN. Human carcinogens: an evaluation study via the COMPACT and HazardExpert procedures. Hum Exp Toxicol 2002, 21:115-122. 10.1191/0960327102ht233oa, 12102536.
17. Marchant CA. Prediction of rodent carcinogenicity using the DEREK system for 30 chemicals currently being tested by the National Toxicology Program. The DEREK Collaborative Group. Environ Health Perspect 1996, 104(Suppl 5):1065-1073. 10.1289/ehp.96104s51065, 1469697, 8933056.
18. Benigni R, Bossa C, Tcheremenskaia O, Worth A. Development of structural alerts for the in vivo micronucleus assay in rodents. EUR 23844 EN 2009, 1-43.
19. Matthews EJ, Contrera JF. A new hightly specific method for predicting the carcinogenic potential of pharmaceuticals in rodents using enhanced MCASEQSAR-ES software. Regul Toxicol Pharmacol 1998, 28:242-264. 10.1006/rtph.1998.1259, 10049796.
20. Price N. Hail Caesar. Chemistry & Industry 2008, 15:18-19.
21. Benfenati E. CAESAR QSAR models for REACH. Chem Central J 2010, 4(Suppl 1):S1-S5.
22. OECD principles Guidance Document on the Validation of (Q)SARModels. Paris, France. Organisation for Economic Cooperation and Development. Environmental Health and Safety Publications. Series on Testing and Assessment. No. 69 2007, 154. OECD principles., http://www.oecd.org/officialdocuments/displaydocumentpdf/?cote=env/jm/mono%282007%292&doclanguage=en
23. Putz MV, Putz AM, Barou R. Spectral-SAR Realization of OECD-QSAR Principles. Int J Chem Model 2011, 3(3):2.
24. Putz MV, Putz AM. Timisoara Spectral-Structure Activity Relationship (Spectral-SAR) Algorithm: From Statistical and Algebraic Fundamentals to Quantum Consequences. Quantum Frontiers of Atoms and Molecules 2011, 539-580. New York: Nova Science, Putz MV.
25. Tarko L, Lupescu I, Groposila-Constantinescu D. Sweetness power QSARs by PRECLAV software. ARKIVOC 2005, 254-271.
26. Martin EJ, Blaney JM, Siani MA, Spellmeyer DC, Wong AK, Moos WH. Measuring diversity: experimental design of combinatorial libraries for drug discovery. J Med Chem 1995, 38:1431-1436. 10.1021/jm00009a003, 7739001.
27. OECD Toolbox Guidance Document for using the (Q)SAR Application Toolbox to develop chemical categories according to the OECD Guidance on Grouping of Chemicals. OECD Toolbox., http://www.oecd.org/document/54/0,3343,en_2649_34379_42923638_1_1_1_1,00.html
28. Fjodorova N, Vračko M, Novič M, Roncaglioni A, Benfenati E. New public QSAR model for carcinogenicity. Chem Central J 2010, 4(Suppl 1):S3.
29. Hypercube, Inc. (2002). HyperChem 7.01 [Program package], 1115 NW 4th St.Gainesville, FL 32608, USA.
30. Hansch C, Kurup A, Garg R, Gao H. Chem-bioinformatics and QSAR: A review of QSAR lacking positive hydrophobic terms. Chem Rev 2001, 101:619-672. 10.1021/cr0000067, 11712499.
31. Putz MV, Lacrǎmǎ AM. Introducing spectral structure activity relationship (S-SAR) analysis. Application to ecotoxicology. Int J Mol Sci 2007, 8:363-391.
32. Lacrǎmǎ AM, Putz MV, Ostafe V. A Spectral-SAR model for the anionic-cationic interaction in ionic liquids: application to Vibrio fischeri ecotoxicity. Int J Mol Sci 2007, 8:842-863.
33. Putz MV, Putz AM, Ostafe V, Chiriac A. Spectral-SAR ecotoxicology of ionic liquids-acetylcholine interaction on E. Electricus species. Int J Chem Model 2010, 2:85-96.
34. Putz MV. QSAR & SPECTRAL-SAR in Computational Ecotoxicology 2011, Ontario: Apple Academics, .
35. Schüürmann G, Ebert R-U, Kühne R. Prediction of physicochemical properties of organic compounds from 2D molecular structure-Fragment methods vs. LFER models. Chimia 2006, 60:691-698.
36. Schüürmann G, Kühne R, Kleint F, Ebert R-U, Rothenbacher C, Herth P. A software system for automatic chemical property estimation from molecular structure. Quantitative Structure-Activity Relationships in Environmental Sciences-VII 1997, 93-114. Pensacola: SETAC Press, Chen F, Schüürmann G.
37. Huijbregts MAJ, Rombouts LJA, Ragas Ad MJ, van de Meent D. Human-toxicological effect and damage factors of carcinogenic and noncarcinogenic chemicals for life cycle impact assessment. Integr Environ Assess Manag 2005, 1:181-244. 10.1897/2004-007R.1, 16639884.
38. Franke R, Gruska A. General introduction to QSAR. Quantitative Structure-Activity Relationhsip (QSAR) Models of Mutagens and Carcinogens 2003, 1-40. Boca Raton: CRC Press, Benigni R.
39. Chicu SA, Putz MV. Köln-Timiöoara molecular activity combined models toward interspecies toxicity assessment. Int J Mol Sci 2009, 10:4474-4497. 10.3390/ijms10104474, 2790119, 20057956.
40. Putz MV, Putz AM, Lazea M, Ienciu L, Chiriac A. Quantum-SAR Extension of the Spectral-SAR Algorithm. Application to Polyphenolic Anticancer Bioactivity. Int J Mol Sci 2009, 10:1193-1214. 10.3390/ijms10031193, 2672025, 19399244.
41. Husserl E. Ideas Pertaining to a Pure Phenomenology and to a Phenomenological Philosophy-Third Book: Phenomenology and the Foundations of the Sciences 1980, Dordrecht: Kluwer, Klein TE, Pohl WE.
42. Caspase-2 IHC Antibody. , http://www.ihcworld.com/products/antibody-datasheets/Caspase2.IW-PA1113.htm
43. Anand P, Kunnumakara AB, Sundaram C, Harikumar KB, Tharakan ST, Lai OS, Sung B, Aggarwal BB. Cancer is a preventable disease that requires major lifestyle changes. Pharmacol Res 2008, 25:2097-2116.
44. Irigaray P, Newby JA, Clapp R, Hardell L, Howard V, Montagnier L, Epstein S, Belpomme D. Lifestyle-related factors and environmental agents causing cancer: an overview. Biomed Pharmacother 2007, 61:640-58. 10.1016/j.biopha.2007.10.006, 18055160.
45. Benigni R, Bossa C, Jeliazkova N, Netzeva T, Worth A. The Benigni/Bossa rules for mutagenicity and carcinogenicity-a module of Toxtree. EUR 23241 EN 2008, 1-69.